Johannes Tobias Neumann, Raphael Twerenbold, Jessica Weimann, Christie M Ballantyne, Emelia J Benjamin, Simona Costanzo, James A de Lemos, Christopher R deFilippi, Augusto Di Castelnuovo, Chiara Donfrancesco, Marcus Dörr, Kai M Eggers, Gunnar Engström, Stephan B Felix, Marco M Ferrario, Ron T Gansevoort, Simona Giampaoli, Vilmantas Giedraitis, Pär Hedberg, Licia Iacoviello, Torben Jørgensen, Frank Kee, Wolfgang Koenig, Kari Kuulasmaa, Joshua R Lewis, Thiess Lorenz, Magnus N Lyngbakken, Christina Magnussen, Olle Melander, Matthias Nauck, Teemu J Niiranen, Peter M Nilsson, Michael H Olsen, Torbjorn Omland, Viktor Oskarsson, Luigi Palmieri, Anette Peters, Richard L Prince, Vazhma Qaderi, Ramachandran S Vasan, Veikko Salomaa, Susana Sans, J Gustav Smith, Stefan Söderberg, Barbara Thorand, Andrew M Tonkin, Hugh Tunstall-Pedoe, Giovanni Veronesi, Tetsu Watanabe, Masafumi Watanabe, Andreas M Zeiher, Tanja Zeller, Stefan Blankenberg, Francisco Ojeda
IMPORTANCE: Identification of individuals at high risk for atherosclerotic cardiovascular disease within the population is important to inform primary prevention strategies. OBJECTIVE: To evaluate the prognostic value of routinely available cardiovascular biomarkers when added to established risk factors. DESIGN, SETTING, AND PARTICIPANTS: Individual-level analysis including data on cardiovascular biomarkers from 28 general population-based cohorts from 12 countries and 4 continents with assessments by participant age...
May 13, 2024: JAMA